期刊文献+

食管鳞癌分泌素-3A1基因启动子甲基化异常 被引量:2

Secretoglobin-3A1 Gene Promoter Hypermethylation Relevant to Esophageal Squamous Cell Carcinoma
下载PDF
导出
摘要 目的研究具有抗癌活性的细胞因子分泌素-3A1基因启动子超甲基化所致该基因表达抑制在我国食管鳞癌发生中的作用。方法用RT-PCR方法检测分泌素-3A1基因在12个食管鳞癌细胞系的表达,并用甲基化特异PCR技术(methylation specific PCR,MSP)检测上述细胞系及37例来自我国河南的原发性食管鳞癌标本分泌素-3A1基因启动子甲基化状态,通过5-aza-dc处理使培养细胞去甲基化,RT-PCR技术检测处理后该基因在Kyse30的重新表达。结果该基因仅在Kyse410、Kyse520和TE8等3个细胞系有表达,5-aza-dc处理可使Kyse30重新表达分泌素-3A1。此外,在18/37(48.6%)例原发性食管鳞癌细胞有分泌素-3A1基因启动子区域的超甲基化。结论启动子超甲基化造成分泌素-3A1基因在上述食管鳞癌细胞系表达抑制,原发性食管鳞癌细胞分泌素-3A1基因启动子超甲基化提示该基因表达抑制可能与食管鳞癌发生有关。 Objective To study the involvement of promoter region hypermethylation related loss of gene expression of Secretoglobin-3A1 (SCGB3A1), a cytokine with tumor suppressing activity, in the tumorigenesis of oesophageal squmous cell carcinoma (ESCC). Methods RT-PCR was used to detect SCGB3A1 expression in 12 cell lines derived from human ESCC; methylation specific PCR (MSP) was used to test the methylation statue of SCGB3A1 gene's.promoter region CpG island in those ESCC cell lines and 37 primary ESCC specimen from Henan China. DNA de-methylation regent 5-aza-dc was also used to treat the SCGB3A1 silencing cell line in vitro. Results Only Kyse410, Kyse520 and TE8 from 12 tested cell lines had detectable SCGB3A1 gene expression. As revealed by using MSP, SCGB3A1 gene silencing was associated with the hypermethylation state throughout its promoter region, which was further confirmed by the detection of SCGB3A1 gene re-expression in Kyse30, after in vitro de-methylation treat- ment with 5-aza-dc. Moreover, we found that 18/37 (48.6%) of primary ESCC specimens tested had a high density of methylated CpG in SCGB3A1 promoter region. Conclusion Data here suggest promoter-hypermethylation related loss of SCGB3A1 gene expression is relevant to ESCC.
出处 《国际遗传学杂志》 CAS 2006年第1期1-3,19,共4页 International Journal of Genetics
基金 国家自然科学基金主任基金(No.30540081)
关键词 食管癌 甲基化 分泌素-3A1 Esophageal carcinoma Methylation SCGB3A1
  • 相关文献

参考文献12

  • 1Porter DA, Krop IE, Nasser S, et al. A SAGE (serial analysis of gene expression) view of breast tumor progression. Cancer Res, 2001,61:5697-5702.
  • 2Krop IE, Sgroi D, Porter DA, et al. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells. Proc Natl Acad Sci U S A, 2001,98:9796-9801.
  • 3Antonio M, Fabio.B, Carla M, et al, Down regulation of high in normal-1 (HIN-1) is a frequent event in stage 1 non-small cell lung cancer and correlates with poor clinical outcome. Clin Cancer Res, 2004,10:1338-1343.
  • 4Krop I, Player A, Tablante A, et al. Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor types. Mol Cancer Res, 2004,2:489-494.
  • 5Krop I, Parker MT, Bloushtain-Qimron N, et al, HIN-1, an inhibitor of cell growth, invasion, and AKT activation. Cancer Res 2005,65: 9659-9669.
  • 6Lu F, Gladen A, Diehl JA. An altematively spliced cyclin D1 isoform,cyclin D1b, is a nuclear oncogene. Cancer Res, 2003,63:7056-7061.
  • 7Shimada Y, Imamura M, Wagata T, et al. Characterization of 21 newly established esophageal cancer cell lines. Cancer, 1992, 15; 69:277-284.
  • 8Shigematsu H, Suzuki M, Takahashi T, et al. Aberrant methylation of HIN-1 (high in normal-1) is a frequent event in many human malignancies, Int J Cancer, 2005,113:600-604.
  • 9Luo L, Lu FM, Hart S, et al. Ataxia-telangiectasia and T-cell leukemias: no evidence for somatic ATM mutation in sporadic T-ALL or for hypermethylation of the ATM-NPAT/E14 bidirectional promoter in T-PLL.Cancer Res, 1998,58:2293-2297.
  • 10Herman JG, Graft JR, Myohanen S, et al. Methylation-specific PCR:a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A, 1996,93:9821 -9826.

同被引文献20

  • 1郭晓青,王士杰,张健慧,丛庆文,张立玮,郭炜,王小玲,邝刚.食管鳞状细胞癌及癌前病变组织中p16基因甲基化的研究[J].肿瘤防治杂志,2005,12(7):495-498. 被引量:10
  • 2姚群峰,康新江,郝巧玲,曾卫,周宜开.巢式甲基化特异性PCR检测食管癌病人血清中p16基因启动子区过甲基化[J].肿瘤防治研究,2005,32(8):463-466. 被引量:5
  • 3张功员,马春晓,刘秋亮,乐晓平,丁一,张钦宪.食管癌组织中hMSH2基因启动子区甲基化检测[J].中华肿瘤杂志,2005,27(9):541-543. 被引量:12
  • 4Lin J, Beerm DG. Molecular biology of upper gastrointestinal malignancies[J]. Semin Oncol, 2004,31(4) : 476-486.
  • 5Sakaguchi S, Yokokawa Y, Hou J, et al. Environmental exposure and p53 mutations in esophageal cancer patients in areas of low and high incidence of esophageal cancer in China [J]. Tohoku J Exp Meal,2005,207(4) :313-324.
  • 6Gonzalez-Zulueta M,Bender CM, Yang AS, et al. Methylation of the 5'CpG island of the p16/CDKN2 tumor suppressor gene in noumal and transformed human tissues correlates with gene silencing[J]. Cancer Res,1995,55(20) :4531-4535.
  • 7Klump B, Hsieh CJ, Holzmann K, et al. Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus[J]. Gastroenterology, 1998,115 (6) : 1381- 1386.
  • 8HardieLJ, Darnton SJ,Wallis YL, et al. p16 expression in Barret's esophagus and esophageal adenocarcinoma: association with genetic and epigenetic alterations[J].Cancer Lett,2005,217(2):221-230.
  • 9Ohtani-Fujita N, Fujita T, Aoike A, et al. CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene[J]. Oncogene, 1993,8(4) : 1063-1067.
  • 10Zheng S,Ma X,Zhang L,et al. Hypermethylation of the 5'CpG Island of the FHIT Gene Is associated with hyperdiploid and transloeation negative subtypes of pediatric leukemia [J ]. Cancer Res,2004,64(6) :2000-2006.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部